- Home
- LBTYA vs AAPG Comparison
LBTYA vs AAPG Comparison
Compare LBTYA & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- AAPG
- Stock Information
- Founded
- LBTYA 2004
- AAPG 2009
- Country
- LBTYA Bermuda
- AAPG China
- Employees
- LBTYA N/A
- AAPG N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYA Telecommunications
- AAPG Health Care
- Exchange
- LBTYA Nasdaq
- AAPG Nasdaq
- Market Cap
- LBTYA 3.7B
- AAPG 3.6B
- IPO Year
- LBTYA N/A
- AAPG 2025
- Fundamental
- Price
- LBTYA $11.53
- AAPG $45.00
- Analyst Decision
- LBTYA Buy
- AAPG Buy
- Analyst Count
- LBTYA 5
- AAPG 1
- Target Price
- LBTYA $14.96
- AAPG N/A
- AVG Volume (30 Days)
- LBTYA 2.2M
- AAPG 7.2K
- Earning Date
- LBTYA 08-01-2025
- AAPG 08-20-2025
- Dividend Yield
- LBTYA N/A
- AAPG N/A
- EPS Growth
- LBTYA N/A
- AAPG N/A
- EPS
- LBTYA N/A
- AAPG N/A
- Revenue
- LBTYA $4,633,000,000.00
- AAPG $134,352,180.00
- Revenue This Year
- LBTYA $8.82
- AAPG N/A
- Revenue Next Year
- LBTYA $1.16
- AAPG $404.41
- P/E Ratio
- LBTYA N/A
- AAPG N/A
- Revenue Growth
- LBTYA 81.79
- AAPG 341.77
- 52 Week Low
- LBTYA $9.03
- AAPG $16.50
- 52 Week High
- LBTYA $21.56
- AAPG $45.40
- Technical
- Relative Strength Index (RSI)
- LBTYA 74.57
- AAPG N/A
- Support Level
- LBTYA $10.81
- AAPG N/A
- Resistance Level
- LBTYA $11.14
- AAPG N/A
- Average True Range (ATR)
- LBTYA 0.36
- AAPG 0.00
- MACD
- LBTYA 0.09
- AAPG 0.00
- Stochastic Oscillator
- LBTYA 96.94
- AAPG 0.00
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.